WHO WE HELP / AI COMPANIES

Test the product against real drug-development work

VED supplies the domain framing, expert network and evaluation discipline that life-sciences AI products need before a compelling demo becomes a trusted workflow.

VED working method

  1. 01Tasks
  2. 02Rubrics
  3. 03Trust
Decision-ready direction
01

Where AI builders need specialist help

01

Representative tasks

Create realistic, appropriately bounded work from regulatory, clinical, biomarker, writing and evidence contexts.

02

Expert rubrics

Define what good reasoning, evidence use, uncertainty and escalation look like.

03

Blinded evaluation

Run multiple expert reviews, adjudicate disagreement and analyse recurring failure modes.

04

Workflow fit

Determine where the product belongs, what it replaces, what must remain human and which controls are essential.

05

Customer credibility

Turn evaluation results into a defensible product claim, implementation boundary and improvement backlog.

06

Expert supply

Recruit and manage the right professionals for repeated evaluation, red-team or customer-workflow programmes.

02

Why VED—not a broad expert marketplace

Drug-development work is cross-functional, regulated and context-dependent. VED combines domain leadership with expert operations: the person designing the evaluation understands why the answer matters, while the network provides the depth and scale to test it.

03

Commercial formats

  • Evaluation-design workshop
  • Four-to-six-week benchmark or red-team sprint
  • Managed expert panel for repeated product evaluation
  • Customer workflow and implementation advisory
  • Specialist expert recruitment for internal AI teams

Start with the constraint

What must your programme decide, prove or deliver next?

Share the situation, evidence and timing. We will propose the smallest credible first step.